MedPath

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

Phase 2
Recruiting
Conditions
Primary Brain Tumor
Astrocytoma
Oligodendroglioma
Primary Central Nervous System (CNS) Lymphoma
Meningioma
Glioblastoma
Interventions
Behavioral: Cognitive Behavioral Therapy for Insomnia
Registration Number
NCT06439420
Lead Sponsor
Virginia Commonwealth University
Brief Summary

This study seeks to investigate an evidence-based, manualized, behavioral health intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I), in individuals with primary brain tumors (PBT) and insomnia. Our project will assess the feasibility and acceptability of recruitment, enrollment, data collection procedures, and retention of individuals with PBT and insomnia in the behavioral health intervention, CBT-I, and investigate the potential benefits of CBT-I within this at-risk and understudied population. In the long term, the goals are to expand treatment options for neuro-oncology patients and improve their mission readiness and overall wellbeing.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Primary brain tumor diagnosis (grade I-IV)
  • >/=2weeks post-cranial resection (if applicable)
  • >/=1 month post-radiation therapy (if applicable)
  • Able to understand, speak, and read English
  • Absence of major cognitive concerns
  • Meet Diagnostic and statistical manual of mental disorders version 5 (DSM-V) diagnostic criteria for insomnia
  • Reliable internet connection
Exclusion Criteria
  • Major communication difficulties that would prohibit effective intervention
  • Inability to attend weekly virtual group meetings
  • Inability to understand and provide informed consent
  • Currently a prisoner or residing in a correctional facility

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Telehealth Cognitive Behavioral Therapy for InsomniaCognitive Behavioral Therapy for Insomnia-
Primary Outcome Measures
NameTimeMethod
Rate of baseline assessment completionWeek 1

Number of participants that complete the baseline assessment

Rate of consent to screening proceduresBaseline (Day 1)

Number of participants that consent to screening procedures

Rate of post-intervention assessment completionWeek 6

The number of participants that complete the post-intervention assessment

Acceptability of quantity of assessmentsWeek 18

Satisfaction rating of quantity of assessments on a scale of 1-5 with 5 being the best

Rate of intervention attritionWeek 6

The number of participants that do not complete the CBT-I intervention

Acceptability of duration of assessmentsWeek 18

Satisfaction ratings of duration of assessments on a scale of 1-5 with 5 being the best

Rate of those eligible enrollingBaseline (Day 1)

Number of participants that are eligible to enroll to the protocol

Rate of follow-up assessment completionWeek 18

The number of participants that complete the follow-up assessment

Acceptability of timing of assessmentsWeek 18

Satisfaction ratings of timing of assessments on a scale of 1-5 with 5 being the best

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath